Schedule 13D ownership disclosure
Olema Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 60862P106
Event date: 2024-06-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,233,875
- Percent of class
- 5.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000426
- Form type
- SC 13D
- Filer
- Logos Global Management LP
- CIK
- CIK 1792126
- Filed
- Jun 06, 2024
- Reporting period
- Jun 04, 2024
- Description
- Schedule 13D beneficial ownership